Cargando…
miR-342 inhibits glioma cell proliferation by targeting GPRC5A
Accumulating evidence suggests that microRNAs (miRNAs) play a key role in the biological behaviors and progression of glioma. However, the function and bio-molecular mechanisms of miR-342 in glioma remain largely unclear. In the present study, reverse transcription quantitative-polymerase chain reac...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6579993/ https://www.ncbi.nlm.nih.gov/pubmed/31115523 http://dx.doi.org/10.3892/mmr.2019.10242 |
_version_ | 1783427946657087488 |
---|---|
author | Wang, Jianjiao Yang, Yan Cao, Yuandong Tang, Xinyu |
author_facet | Wang, Jianjiao Yang, Yan Cao, Yuandong Tang, Xinyu |
author_sort | Wang, Jianjiao |
collection | PubMed |
description | Accumulating evidence suggests that microRNAs (miRNAs) play a key role in the biological behaviors and progression of glioma. However, the function and bio-molecular mechanisms of miR-342 in glioma remain largely unclear. In the present study, reverse transcription quantitative-polymerase chain reaction and western blotting were performed to determine the mRNA and protein expression levels of the factors investigated. MTT assay was performed to examine the proliferation rates. Luciferase reporter assay was performed to test the binding between miRNA-342 and its putative target. Data indicated that miR-342 expression was markedly decreased in human glioma tissues and cell line U87, and reduced miR-342 expression significantly promoted cell proliferation. In order to explore the mechanisms, G-protein coupled receptor family C group 5 member A (GPRC5A) was identified as a target of miR-342 and depletion of GPRC5A suppressed cell proliferation. Our findings demonstrated that miR-342 regulates the cell proliferation of glioma by targeting GPRC5A, which indicates that miR-342 is a target of interest regarding the treatment of refractory glioma, and it may provide a promising prognostic and therapeutic strategy for glioma treatment. |
format | Online Article Text |
id | pubmed-6579993 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-65799932019-07-05 miR-342 inhibits glioma cell proliferation by targeting GPRC5A Wang, Jianjiao Yang, Yan Cao, Yuandong Tang, Xinyu Mol Med Rep Articles Accumulating evidence suggests that microRNAs (miRNAs) play a key role in the biological behaviors and progression of glioma. However, the function and bio-molecular mechanisms of miR-342 in glioma remain largely unclear. In the present study, reverse transcription quantitative-polymerase chain reaction and western blotting were performed to determine the mRNA and protein expression levels of the factors investigated. MTT assay was performed to examine the proliferation rates. Luciferase reporter assay was performed to test the binding between miRNA-342 and its putative target. Data indicated that miR-342 expression was markedly decreased in human glioma tissues and cell line U87, and reduced miR-342 expression significantly promoted cell proliferation. In order to explore the mechanisms, G-protein coupled receptor family C group 5 member A (GPRC5A) was identified as a target of miR-342 and depletion of GPRC5A suppressed cell proliferation. Our findings demonstrated that miR-342 regulates the cell proliferation of glioma by targeting GPRC5A, which indicates that miR-342 is a target of interest regarding the treatment of refractory glioma, and it may provide a promising prognostic and therapeutic strategy for glioma treatment. D.A. Spandidos 2019-07 2019-05-15 /pmc/articles/PMC6579993/ /pubmed/31115523 http://dx.doi.org/10.3892/mmr.2019.10242 Text en Copyright: © Wang et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Wang, Jianjiao Yang, Yan Cao, Yuandong Tang, Xinyu miR-342 inhibits glioma cell proliferation by targeting GPRC5A |
title | miR-342 inhibits glioma cell proliferation by targeting GPRC5A |
title_full | miR-342 inhibits glioma cell proliferation by targeting GPRC5A |
title_fullStr | miR-342 inhibits glioma cell proliferation by targeting GPRC5A |
title_full_unstemmed | miR-342 inhibits glioma cell proliferation by targeting GPRC5A |
title_short | miR-342 inhibits glioma cell proliferation by targeting GPRC5A |
title_sort | mir-342 inhibits glioma cell proliferation by targeting gprc5a |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6579993/ https://www.ncbi.nlm.nih.gov/pubmed/31115523 http://dx.doi.org/10.3892/mmr.2019.10242 |
work_keys_str_mv | AT wangjianjiao mir342inhibitsgliomacellproliferationbytargetinggprc5a AT yangyan mir342inhibitsgliomacellproliferationbytargetinggprc5a AT caoyuandong mir342inhibitsgliomacellproliferationbytargetinggprc5a AT tangxinyu mir342inhibitsgliomacellproliferationbytargetinggprc5a |